{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T06:06:48Z","timestamp":1700633208635},"reference-count":67,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T00:00:00Z","timestamp":1290556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Nurse Practitioners"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p> <jats:bold>Purpose:<\/jats:bold> This article reviews the diagnosis and current treatment options for gastroesophageal reflux disease (GERD) available to nurse practitioners, with a focus on advances in proton pump inhibitor (PPI) therapy.<\/jats:p><jats:p> <jats:bold>Data Sources:<\/jats:bold> Review of scientific literature and clinical management guidelines for GERD treatment and PPI therapy from the PubMed database, Google Scholar, and other World Wide Web resources.<\/jats:p><jats:p> <jats:bold>Conclusions:<\/jats:bold> A number of safe and effective treatment options exist for GERD. Recent developments in PPI technology may begin to address unmet needs in PPI therapy.<\/jats:p><jats:p> <jats:bold>Implications for Practice:<\/jats:bold> GERD is commonly diagnosed and treated by nurse practitioners in the primary care setting. Acid suppression therapy is the primary medical therapy for GERD. PPI therapy provides symptomatic relief of heartburn and regurgitation, as well as effective healing and maintenance of erosive esophagitis. Newer PPIs lengthen the duration of acid suppression and allow for more flexibility in dosing, which may improve medication adherence and decrease episodes of acid breakthrough.<\/jats:p>","DOI":"10.1111\/j.1745-7599.2010.00578.x","type":"journal-article","created":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T02:42:18Z","timestamp":1290652938000},"page":"674-683","source":"Crossref","is-referenced-by-count":6,"title":["The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease"],"prefix":"10.1111","volume":"22","author":[{"given":"Elizabeth A.","family":"Friedlander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Pallentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"VanBeuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,24]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.04.014"},{"key":"e_1_2_12_3_1","volume-title":"NEXIUM\u00ae (esomeprazole magnesium) Prescribing Information","author":"AstraZeneca Pharmaceuticals LP","year":"2008"},{"key":"e_1_2_12_4_1","volume-title":"PRILOSEC\u00ae (omeprazole) Prescribing Information","author":"AstraZeneca Pharmaceuticals LP","year":"2008"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199509020-00002"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.03.006"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80087-4"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6440"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903035745"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178669"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0885-2"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.051821"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41217.x"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212163072503"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03189.x"},{"key":"e_1_2_12_16_1","volume-title":"ACIPHEX\u00ae (rabeprazole sodium) Prescribing Information","author":"Eisai Co. Ltd","year":"2009"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.077"},{"key":"e_1_2_12_18_1","first-page":"69","volume-title":"The Burden of Digestive Diseases in the United States","author":"Everhart J. E.","year":"2008"},{"issue":"3","key":"e_1_2_12_19_1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.14309\/00000434-200910003-00029","article-title":"Dexlansoprazole MR for treatment for nocturnal heartburn in patients with symptomatic nonerosive GERD [abstract]","volume":"104","author":"Fass R.","year":"2009","journal-title":"American Journal of Gastroenterology"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02531.x"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.08.060"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.11.021"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0190"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02911.x"},{"issue":"7","key":"e_1_2_12_25_1","first-page":"1311","article-title":"Management of gastroesophageal reflux disease","volume":"68","author":"Heidelbaugh J. J.","year":"2003","journal-title":"Am Fam Physician"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02709.x"},{"issue":"3","key":"e_1_2_12_27_1","first-page":"240","article-title":"Gastroesophageal reflux disease","volume":"52","author":"Howden C. W.","year":"2003","journal-title":"Journal of Family Practice"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04119.x"},{"issue":"1","key":"e_1_2_12_29_1","first-page":"S7","article-title":"Pharmacokinetics of pantoprazole in man","volume":"34","author":"Huber R.","year":"1996","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00021.x"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.7.649"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07665.x"},{"key":"e_1_2_12_33_1","volume-title":"Comparative Effectiveness of Management Strategies For Gastroesophageal Reflux Disease. Comparative Effectiveness Review No. 1","author":"Ip S.","year":"2005"},{"issue":"3","key":"e_1_2_12_34_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.1999.00022.x","article-title":"Review article: cytochrome P450 and the metabolism of proton pump inhibitors\u2013emphasis on rabeprazole","volume":"13","author":"Ishizaki T.","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"e_1_2_12_35_1","first-page":"98","article-title":"Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies","volume":"8","author":"Johnson D. A.","year":"2008","journal-title":"Reviews in Gastroenterological Disorders"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00285.x"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.08.045"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.965"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016062508580"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03979.x"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.172"},{"key":"e_1_2_12_42_1","volume-title":"Drug Class Review on Proton Pump Inhibitors","author":"McDonagh M.","year":"2006"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03954.x"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08783.x"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.04.005"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1010"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01178.x"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.35.040195.001425"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02943.x"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00257.x"},{"key":"e_1_2_12_51_1","volume-title":"ZEGERID\u00ae (omeprazole\/sodium bicarbonate) Prescribing Information","author":"Santarus Inc","year":"2008"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000091298"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03933.x"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1586\/ecp.09.33"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02889.x"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.18.2331"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.72241000.x"},{"key":"e_1_2_12_58_1","volume-title":"KAPIDEX\u00ae (dexlansoprazole) Prescribing Information","author":"Takeda Pharmaceuticals America Inc","year":"2009"},{"key":"e_1_2_12_59_1","volume-title":"PREVACID\u00ae (lansoprazole) Prescribing Information","author":"Takeda Pharmaceuticals America Inc","year":"2009"},{"issue":"10","key":"e_1_2_12_60_1","first-page":"933","article-title":"Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease","volume":"63","author":"Tefera L.","year":"1997","journal-title":"Am Surg"},{"key":"e_1_2_12_61_1","unstructured":"US Food and Drug Administration. (2009).Information for Healthcare Professionals: Update to the labeling of Clopidogrel Bisulfate (marketed as Plavix) to alert healthcare professionals about a drug interaction with omeprazole (marketed as Prilosec and Prilosec OTC). Retrieved March 4 2010 fromhttp:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/DrugSafetyInformationforHeathcareProfessionals\/ucm190787.htm"},{"key":"e_1_2_12_62_1","unstructured":"US Food and Drug Administration. (2010).FDA Drug Safety Communication: Possible increased risk of fractures of the hip wrist and spine with the use of the proton pump inhibitors. Retrieved May 27 2010 fromhttp:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm213206.htm"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.2165\/0044011-200929010-00004"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802693883"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200525060-00004"},{"key":"e_1_2_12_67_1","volume-title":"PROTONIX\u00ae(pantoprazole sodium) Prescribing Information","author":"Wyeth Pharmaceuticals Inc","year":"2009"},{"issue":"9","key":"e_1_2_12_68_1","first-page":"466","article-title":"Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers","volume":"32","author":"Yasuda S.","year":"1994","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"}],"container-title":["Journal of the American Academy of Nurse Practitioners"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1745-7599.2010.00578.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1745-7599.2010.00578.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T18:00:18Z","timestamp":1698688818000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1745-7599.2010.00578.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,24]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1745-7599.2010.00578.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1745-7599.2010.00578.x","archive":["Portico"],"relation":{},"ISSN":["1041-2972","1745-7599"],"issn-type":[{"value":"1041-2972","type":"print"},{"value":"1745-7599","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,24]]}}}